enzalutamide
pfizer,astellas
['enzamet']
 phiii enzamet updated survival in #mhspc median f/u 68 mos sustained os benefit w/enza + nsaa vs nsaa even w/76% receiving nht at pd in control, 45% w/enza + early docetaxel planned w/potential signal of benefit in explor analyses (synchronous, high-volume) #asco22 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope